NASDAQ

Ultragenyx Pharmaceutical Inc. (RARE)

♥ 448 Thanks from members

Live price chart, market sentiment, and community perspectives for Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Emil KakkisLeadership: Emil Kakkis (CEO)Leadership: Theodore Hu (CFO)Holder: FMR LLCHolder: BlackRock, Inc.Holder: Vanguard GroupCrysvitaMepseviiDojolvi#Ultragenyx#RARE stock#rare disease biopharma#genetic disorders#Crysvita